Autosomal dominant axonal Charcot-Marie-Tooth disease type 2V (CMT2V) is a very rare inherited nerve disease. It mainly affects the long motor and sensory nerves in the arms and legs. The word “axonal” means the central cable of the nerve (the axon) is damaged, not the myelin covering. People usually develop symptoms in adult life, with burning pain, numbness, tingling, and weakness in the feet and later in the hands. CMT2V is usually linked to variants in the NAGLU gene and follows an autosomal dominant pattern, which means one changed gene from either parent is enough to cause disease. Genetic Diseases Center+2Orpha.net+2
Autosomal dominant axonal Charcot-Marie-Tooth disease type 2V (CMT2V) is a very rare, inherited nerve disease. It mainly damages the long nerves that carry signals between the spinal cord and the legs and, later, the hands. Doctors call this an “axonal hereditary motor and sensory neuropathy,” which means that both movement (motor) and feeling (sensory) nerves are slowly injured, and the injury is mainly in the axon, the long “wire” part of the nerve. Genetic Diseases Center+1 In CMT2V, a single faulty copy of a gene called NAGLU on chromosome 17 is enough to cause disease. This pattern is called autosomal dominant. Most people develop symptoms in adulthood, often starting with repeated leg pain, sometimes with cramps, then numbness, tingling, and loss of reflexes and vibration sense in the feet, and later in the hands. Many people also have sleep problems and mild unsteady walking. Disease Ontology+2Genetic Diseases Center+2
There is no cure that can stop or reverse CMT2V today. Doctors focus on controlling pain, protecting muscles and joints, and helping people stay mobile and independent. This is done with a mix of physical therapy, bracing, surgery when needed, pain medicines, and lifestyle changes. New treatments, such as gene and muscle-targeted drugs, are being studied in clinical trials, but none are yet approved specifically for CMT or CMT2V. Charcot-Marie-Tooth Disease+3PMC+3NMD Pharma+3
CMT2V belongs to the wider group “Charcot-Marie-Tooth disease type 2” (CMT2), which includes many axonal forms of CMT caused by different genes. All these forms share common features such as slowly progressive weakness, muscle wasting, and sensory loss in the feet and hands, but CMT2V is especially known for painful symptoms in the legs. Charcot-Marie-Tooth Association+2Muscular Dystrophy Association+2
This information is for education only. It cannot replace advice from a neurologist or genetic counselor.
Other names
Doctors and researchers use several other names for the same condition. Knowing these names can help when you search the internet or medical papers: Genetic Diseases Center+2Disease Ontology+2
Autosomal dominant axonal Charcot-Marie-Tooth disease type 2V
Autosomal dominant Charcot-Marie-Tooth disease type 2V
Charcot-Marie-Tooth neuropathy type 2V
CMT2V
Charcot-Marie-Tooth disease caused by mutation in NAGLU
NAGLU Charcot-Marie-Tooth disease
Hereditary adult-onset painful axonal polyneuropathy
All of these terms point to the same basic problem: a dominantly inherited, painful axonal neuropathy linked to NAGLU gene changes. Genetic Diseases Center+2Disease Ontology+2
Types
CMT2V is defined by one main gene (NAGLU), so there are no official “subtypes” with different gene names inside CMT2V. However, in real life, doctors see different clinical patterns in people with the same gene change. These patterns are based on age of onset, how painful it is, and how strong or weak the person becomes. Genetic Diseases Center+2NCBI+2
Classic adult-onset painful form
In this common pattern, people start in early or middle adult life with repeated burning, aching, or sharp pain in the legs. Cramps may or may not be present. Weakness and numbness are mild at first and increase slowly over many years. Genetic Diseases Center+1Painful form with clear sensory ataxia (balance problems)
Some people not only have leg pain, tingling, and numbness, but also “sensory ataxia.” This means they feel unsteady, especially in the dark or with eyes closed, because their brain gets poor position signals from the feet. Genetic Diseases Center+1Form with more visible weakness and foot deformity
A smaller group develops noticeable weakness, thin lower legs, high arches or hammertoes, and foot drop, similar to other CMT types. Pain can still be strong, but here loss of strength and deformity are more obvious. Muscular Dystrophy Association+2Mayo Clinic+2Very mild or almost silent form
Some relatives with the NAGLU mutation have only absent ankle reflexes or slightly reduced vibration sense and maybe mild pain or tingling. They may not realize they have the condition until another family member is tested. Genetic Diseases Center+2NCBI+2
These patterns show that even with the same gene change, severity can be very different between people in the same family. Wikipedia+1
Causes
Before listing causes, it is important to say clearly:
The true basic cause of CMT2V is a disease-causing change (mutation) in the NAGLU gene. Other items below are factors that help explain how nerve damage happens or what can make symptoms better or worse; they do not “replace” the gene cause. Disease Ontology+2Charcot-Marie-Tooth Association+2
Pathogenic mutation in the NAGLU gene
CMT2V happens when there is a harmful change in one copy of the NAGLU gene, which makes an enzyme called N-acetyl-α-glucosaminidase. This change alters the protein’s structure and function and is the primary cause of the disease. Disease Ontology+1Autosomal dominant inheritance
Because the condition is autosomal dominant, a child needs only one mutated gene copy from either parent to develop the disease. Each child of an affected person has a 50% chance of inheriting the mutation. Genetic Diseases Center+1De novo (new) mutation in NAGLU
Sometimes, CMT2V appears in a person with no family history because the NAGLU mutation occurred for the first time in that individual’s egg or sperm cell or very early in development. This is called a “de novo” mutation. Genetic Diseases Center+1Reduced NAGLU enzyme activity
Studies show that people with CMT2V can have lower NAGLU enzyme activity in their white blood cells. This reduced activity may disturb normal breakdown of certain complex sugars in nerve cells, contributing to axonal dysfunction. NCBIAxonal degeneration of motor nerves
In CMT2V, long motor axons that carry signals from the spinal cord to muscles slowly degenerate. Over time, this causes weakness, muscle wasting, and impaired movement, especially in the feet and legs. ScienceDirect+1Axonal degeneration of sensory nerves
Sensory axons that bring touch, pain, vibration, and position sense from the limbs to the spinal cord are also damaged. This leads to numbness, tingling, loss of vibration sense, and sensory ataxia. Genetic Diseases Center+2Muscular Dystrophy Association+2Length-dependent vulnerability of long nerves
The longest nerves, which run from the spine to the feet, are most vulnerable to metabolic and structural stress. That is why symptoms usually start in the feet and legs and only later affect the hands. Mayo Clinic+1Cellular stress from faulty lysosomal function
NAGLU works in lysosomes, which are cell “recycling centers.” When NAGLU is not working properly, breakdown of specific molecules may be less efficient, adding stress to nerve cells and making them more likely to degenerate over many years. NCBI+1Genetic modifiers and background genes
Other genes in a person’s DNA can modify how strongly the NAGLU mutation shows its effect. These “modifier” genes may partly explain why some family members are severely affected while others are mild. Wikipedia+1Age-related changes in nerves
As people grow older, nerve repair becomes less efficient. In someone who already has a NAGLU mutation, these normal age-related changes can unmask or speed up symptoms, which is why CMT2V often appears in adulthood. Genetic Diseases Center+1Co-existing diabetes or metabolic disease (worsening factor)
Diabetes and other metabolic problems can damage peripheral nerves on their own. If a person with CMT2V also has diabetes, nerve damage and symptoms can become worse and appear earlier. Mayo Clinic+1Exposure to nerve-toxic medicines (worsening factor)
Some chemotherapy drugs and other medications are toxic to nerves. In people with any CMT, including CMT2V, these medicines can make neuropathy more severe, so doctors try to avoid or use them with great caution. Mayo Clinic+1Alcohol overuse (worsening factor)
Heavy alcohol use can cause its own peripheral neuropathy. If someone already has CMT2V, alcohol-related nerve damage can add to the inherited neuropathy and increase pain, numbness, and weakness. WikipediaVitamin deficiencies (worsening factor)
Lack of vitamin B12 or other key vitamins can injure nerves. Treating these deficiencies will not cure CMT2V, but it may prevent additional, avoidable damage on top of the genetic neuropathy. Wikipedia+1Repetitive trauma to numb feet
Because feeling is reduced, people may not notice blisters, pressure points, or small injuries on their feet. Repeated minor trauma can harm local nerves further and increase pain and disability. Mayo Clinic+1Poor footwear and unsupported foot posture
Shoes that do not fit well, or lack support for high arches or foot drop, can place abnormal stress on already weak and numb feet, worsening pain and balance problems. Mayo Clinic+1Lack of physical activity and deconditioning
When muscles are already weak, people may avoid activity because of pain or fear of falling. Less movement causes further loss of strength and endurance, making it harder to walk and increasing fatigue. Wikipedia+1Sleep disturbance and chronic pain cycle
Pain often disturbs sleep. Poor sleep lowers pain tolerance and increases fatigue and mood symptoms. This “vicious cycle” does not cause the gene mutation but can greatly worsen how the disease feels day to day. Genetic Diseases Center+1Psychological stress and mood disorders
Living with chronic pain and disability can lead to anxiety or depression. Stress and low mood can make pain feel more intense and reduce motivation for exercise and self-care. Wikipedia+1Unknown or not yet discovered biological factors
Research on CMT2V is still limited. Other pathways, such as changes in energy handling in nerve cells or interactions with other proteins, may also contribute, but they are not yet fully understood. ScienceDirect+1
Symptoms
Symptoms can vary widely, even inside one family. Some people mainly have pain, others have more weakness, and some are very mild. Genetic Diseases Center+2Muscular Dystrophy Association+2
Recurrent leg pain
The hallmark symptom of CMT2V is repeated episodes of leg pain. The pain can be burning, aching, throbbing, or stabbing. At first it may come and go; later it can become more constant and may worsen after long standing or walking. Genetic Diseases Center+1Leg cramps
Some people have painful muscle cramps, especially in the calves or feet, often at night or after activity. These cramps result from irritated motor nerves that send abnormal signals to muscles. Genetic Diseases Center+1Tingling and “pins and needles” in the feet (paresthesias)
Many people feel tingling, prickling, or “pins and needles” in the toes and soles. This is a sign of sensory nerve irritation and is often worse when resting or at night. Genetic Diseases Center+1Numbness or reduced feeling in feet and toes
As more sensory fibers are damaged, light touch, pain, and temperature may become hard to feel in the feet and toes, and later in the hands. People may not notice small injuries or changes in skin. Genetic Diseases Center+2Mayo Clinic+2Loss of vibration sense
Vibration from a tuning fork or electric toothbrush can feel weaker or absent at the ankles and toes. This happens because long sensory fibers carrying vibration signals are damaged. Genetic Diseases Center+1Reduced or absent tendon reflexes
Reflexes such as the ankle jerk may be decreased or completely lost. The doctor sees this when tapping the tendon with a reflex hammer and getting a very small or no response. Genetic Diseases Center+2Muscular Dystrophy Association+2Distal muscle weakness in feet and ankles
Over time, the muscles that lift and move the feet become weak. People may find it hard to run, climb stairs quickly, or stand on heels or toes. Muscular Dystrophy Association+1Muscle wasting in lower legs and sometimes hands
Because muscles are not receiving normal nerve signals, they shrink and become thinner. This can give the lower legs a “stork-like” or “inverted champagne bottle” appearance, and later can affect small hand muscles. Muscular Dystrophy Association+2Mayo Clinic+2Foot drop and tripping
Weak ankle muscles can make it hard to lift the front of the foot. This is called foot drop. People may trip over small obstacles or need to lift their knees higher when walking to avoid catching their toes. Mayo Clinic+1Balance problems and sensory ataxia
Because joint position sense and vibration sense are reduced, the brain gets poor information about where the feet are. This leads to unsteady walking, especially in the dark or with eyes closed. Genetic Diseases Center+2Muscular Dystrophy Association+2Sleep disturbance
Pain, cramps, and tingling often get worse at night. This can make it hard to fall asleep or stay asleep, leading to daytime tiredness and reduced quality of life. Genetic Diseases Center+1Fatigue and reduced stamina
Walking with weak muscles and poor balance requires extra effort. People often become easily tired after short walks or standing for a long time, even if their general health is otherwise good. Muscular Dystrophy Association+1Hand symptoms in later stages
With disease progression, tingling, numbness, and weakness can spread to the hands. Fine tasks like buttoning clothes, using keys, or writing may become more difficult. Mayo Clinic+1Emotional and social impact
Chronic pain, sleep problems, and limitations in walking or working can lead to low mood, worry about the future, and social withdrawal. These are common human responses to a long-term condition. Wikipedia+1Variable onset and progression
Some people first notice symptoms as teens or young adults; others not until middle age or later life. Even in one family, some relatives may be mild and others more severely affected. Genetic Diseases Center+2Muscular Dystrophy Association+2
Diagnostic tests
Doctors use a mix of history, examination, nerve tests, genetic tests, and sometimes imaging to diagnose CMT2V. First they confirm that there is a length-dependent axonal neuropathy, then they look for the specific NAGLU mutation. They also rule out other causes of neuropathy, such as diabetes or vitamin lack. Mayo Clinic+2Muscular Dystrophy Association+2
Physical examination tests
Full neurological examination
The doctor checks muscle strength, tone, reflexes, and different types of sensation in the legs and arms. In CMT2V, they often find distal weakness, loss of ankle reflexes, and reduced vibration and pin-prick sensation in a “glove and stocking” pattern. Muscular Dystrophy Association+1Gait (walking) observation
The doctor watches how the person walks. They look for high-stepping gait, foot drop, frequent tripping, or wide-based, unsteady steps. This helps show how much motor and sensory problems are affecting movement. Muscular Dystrophy Association+1Heel-toe and tandem walking tests
The person is asked to walk on heels, toes, and then in a straight line placing one foot directly in front of the other. Difficulty with these tasks suggests weakness of distal muscles and problems with balance or position sense. Muscular Dystrophy Association+1Romberg test (standing with eyes closed)
The patient stands with feet together and eyes open, then closes their eyes. Increased sway or falling when the eyes are closed suggests sensory ataxia, which is common when long sensory fibers are damaged. Genetic Diseases Center+1Inspection of feet, legs, and hands
The doctor looks for high arches, hammertoes, calluses, muscle wasting, and skin changes from reduced feeling. These visible signs support the diagnosis of a chronic hereditary neuropathy. Mayo Clinic+1
Manual and bedside tests
Vibration testing with a tuning fork
A metal tuning fork is placed on the ankle or toe. The patient says when the vibration is felt and when it stops. In CMT2V, vibration sense is usually reduced or lost at the toes and ankles. Genetic Diseases Center+1Light touch and monofilament testing
The doctor uses cotton or a thin nylon filament to test light touch on the feet and hands. Reduced ability to feel these gentle touches is a sign of sensory nerve damage. Mayo Clinic+1Pin-prick and temperature testing
A small sterile pin or a cold and warm object is used to test pain and temperature sense. Abnormal results show that small sensory fibers are involved, which is common in painful axonal neuropathies. Genetic Diseases Center+1Manual muscle testing (MMT)
The doctor tests strength by asking the patient to push or pull against their hand in different directions. This helps grade weakness in specific muscle groups, such as ankle dorsiflexion for foot drop. Muscular Dystrophy Association+1Pain scales and symptom questionnaires
Simple rating scales (for example, 0 to 10 for pain) and questionnaires about daily function, sleep, and mood help to measure how severe symptoms are and how they affect everyday life. Genetic Diseases Center+1
Laboratory and pathological tests
Genetic testing for NAGLU mutations
A blood sample is sent for DNA testing. In someone with a compatible neuropathy, finding a disease-causing NAGLU mutation confirms CMT2V. Often this is done as part of a large CMT gene panel. Disease Ontology+2NCBI+2NAGLU enzyme activity testing (specialized)
In some centers or research labs, doctors may measure NAGLU enzyme activity in blood cells. In reported CMT2V families, activity has been moderately reduced compared with healthy controls, helping support the link between the mutation and disease. NCBIBasic blood tests to rule out other causes
Tests such as blood sugar, HbA1c, vitamin B12, thyroid function, kidney and liver tests are done to exclude other causes of neuropathy like diabetes, vitamin deficiency, or systemic disease. These conditions can mimic or worsen CMT symptoms. Mayo Clinic+1Autoimmune and infection screening
If the presentation is unusual, doctors may test for autoimmune antibodies, infections, or inflammatory markers to rule out acquired neuropathies, such as immune-mediated or vasculitic neuropathies, which need different treatment. WikipediaNerve biopsy (rarely needed)
In difficult cases, a small sensory nerve from the ankle may be removed and examined under a microscope. In axonal CMT, including CMT2V, this typically shows loss of axons rather than primary myelin damage, but today biopsy is used far less because genetic testing is more precise. Wikipedia+1
Electrodiagnostic tests
Nerve conduction studies (NCS)
Small electrical pulses are given to nerves, and responses are recorded. In CMT2V, motor and sensory responses are low in size (reduced amplitudes) but conduction speeds are near normal or only mildly slowed, which fits an axonal, not demyelinating, neuropathy. Muscular Dystrophy Association+2Wikipedia+2Electromyography (EMG)
A thin needle electrode is placed into muscles to record electrical activity. EMG in CMT2V often shows signs of chronic denervation and re-innervation, meaning that some motor units have died while others try to take over. Mayo Clinic+1Somatosensory evoked potentials (SSEP) in selected cases
SSEPs measure how sensory signals travel from limbs to the brain. They can show slowed or reduced responses along sensory pathways in complex cases, helping to separate peripheral nerve disease from spinal cord or brain problems. Wikipedia+1
Imaging tests
MRI of spine or plexus to exclude other causes
MRI scans of the spine or lumbosacral plexus do not diagnose CMT2V directly, but they help rule out other causes of leg pain and sensory loss, such as disc herniation, spinal stenosis, or tumors. This is important when symptoms are atypical. Mayo Clinic+1X-rays or MRI of feet and ankles; peripheral nerve ultrasound
X-rays can show high arches, hammertoes, or other foot deformities that result from long-standing muscle imbalance. In some centers, ultrasound or MRI of peripheral nerves is used to study nerve size and structure, although findings in axonal CMT are often subtle. Mayo Clinic+1
Non-Pharmacological Treatments
1. Individualized physiotherapy program
Physiotherapy is one of the most important non-drug treatments for CMT2V. A physiotherapist designs exercises to keep muscles strong and joints flexible. The purpose is to slow muscle wasting, prevent contractures, and improve walking and balance. The main mechanism is simple: repeated, safe movement sends signals through the nerves and muscles, which helps maintain strength, coordination, and circulation, and reduces stiffness and fatigue over time. Physiopedia+2ScienceDirect+2
2. Stretching and range-of-motion exercises
Daily stretching of ankles, knees, hips, and fingers helps keep joints moving freely. The purpose is to prevent muscles and tendons from shortening, which can lead to deformities like foot drop or clawed toes. The mechanism is gentle, repeated lengthening of muscles and soft tissues. This reduces stiffness, improves posture, and lowers the risk of painful contractures and joint damage later in life. Physiopedia+1
3. Strength and resistance training
Light resistance exercises with bands or small weights help preserve muscle power around weak ankles, knees, and hands. The purpose is to support everyday activities such as standing, climbing stairs, and gripping objects. The mechanism is progressive overload: small, controlled resistance makes muscle fibers adapt and become stronger. In CMT2V, therapists use low to moderate intensity to avoid over-fatigue of already weak nerves and muscles. Physiopedia+1
4. Balance and coordination training
Many people with CMT2V have poor balance because their feet are numb and ankle muscles are weak. Balance exercises such as standing on one leg (with support), heel-to-toe walking, or using balance boards help the brain learn to use vision and remaining sensation better. The purpose is to cut the risk of falls. The mechanism is neuroplasticity: repeated practice teaches the nervous system to adjust posture automatically. The Physio Lab+1
5. Gait training and walking practice
Gait training is supervised walking practice, sometimes on a treadmill or using parallel bars. The purpose is to improve the pattern of stepping, increase walking speed, and reduce the energy cost of each step. The mechanism is repeated task-specific practice, often with cues or assistive devices, so the person learns safer foot placement, better knee control, and more stable hip movement, even with weak nerves. ScienceDirect+1
6. Occupational therapy for hand and daily tasks
Occupational therapists teach ways to adapt fine hand tasks like buttoning clothes, writing, or using a phone when fingers are weak or numb. The purpose is to keep independence at home, at school, and at work. The mechanism is practical problem-solving and training with adaptive tools (big-handled pens, Velcro fasteners, special keyboards) so people can still do daily activities despite nerve damage. Muscular Dystrophy Association
7. Ankle–foot orthoses (AFOs)
AFOs are plastic or carbon fiber braces worn inside or over the shoes to hold the ankle in a stable position. The purpose is to treat or prevent foot drop, improve balance, and reduce falls. The mechanism is mechanical support: the brace keeps the foot from pointing down and helps it clear the ground during swing, so walking becomes smoother and safer, even when ankle muscles are weak. Physiopedia+2ScienceDirect+2
8. Special footwear and insoles
People with CMT2V often have high arches, hammer toes, and pressure points. Custom shoes and insoles spread weight more evenly and protect the skin. The purpose is to decrease pain and prevent ulcers and calluses. The mechanism is pressure redistribution and better alignment of the foot, which lowers abnormal stress on bones and joints with each step and improves stability. nhs.uk+1
9. Hand splints and wrist supports
Soft or rigid splints can be used around the wrist and fingers if hand weakness causes instability or deformity. The purpose is to keep joints in a safe position, improve grip, and reduce pain. The mechanism is external stabilization: the splint takes over some of the work of weak muscles, which prevents excessive bending, lowers strain on joints, and helps with functional tasks like holding a cup. Muscular Dystrophy Association
10. Pain-focused psychological therapy (for example CBT)
Chronic neuropathic pain can increase anxiety, poor sleep, and depression. Cognitive-behavioural therapy (CBT) and other pain management programs teach coping skills, relaxation, pacing, and ways to change unhelpful thoughts about pain. The purpose is not to deny pain, but to reduce its impact on life. The mechanism is brain-level: by changing thoughts, attention, and behaviour, pain signals are processed differently and may feel less overwhelming. Charcot-Marie-Tooth Association+1
11. Education and self-management training
Education sessions explain what CMT2V is, why symptoms happen, and which activities are safe. The purpose is to give people the knowledge to protect their nerves and joints and avoid harmful habits. The mechanism is informed decision-making: when someone understands their disease, they are more likely to do regular exercise, foot care, and weight control, which all slow complications. PMC+1
12. Regular aerobic exercise
Low-impact aerobic activities such as swimming, cycling, or walking improve heart and lung fitness. The purpose is to increase general energy, decrease fatigue, and support healthy weight. The mechanism is improved blood flow, better oxygen delivery to muscles, and positive effects on mood and sleep. Exercise is chosen to be gentle on weak feet and ankles but still challenging enough to gain benefit. Physiopedia+1
13. Weight management and nutrition counselling
Extra body weight makes walking harder and increases stress on weak ankles and feet. Meeting a dietitian can help create a balanced meal plan to keep body weight in a healthy range. The purpose is to reduce joint strain and improve mobility. The mechanism is simple physics: less body mass means less force through the legs, which reduces pain and lowers the risk of early joint damage. Muscular Dystrophy Association
14. Assistive devices (canes, walkers, wheelchairs)
Some people with advanced CMT2V benefit from canes, forearm crutches, walkers, or wheelchairs for long distances. The purpose is safety and independence, not to “give up on walking.” The mechanism is external support: devices widen the base of support, reduce load through weak legs, and make it easier to travel longer distances without falls or extreme fatigue. Medscape eMedicine+1
15. Workplace and school adaptations
Ergonomic chairs, height-adjustable desks, speech-to-text software, or flexible schedules can help people with CMT2V stay in school or work. The purpose is to fit the environment to the person, not the other way round. The mechanism is removal of physical and fatigue-related barriers, so tasks can be done with less pain and strain, protecting long-term function and mental health. Medscape eMedicine
16. Podiatry and foot care
Regular visits to a podiatrist help keep nails trimmed, calluses managed, and small wounds treated early. The purpose is to prevent infections, ulcers, and deformity progression. The mechanism is early detection: careful inspection and quick treatment of minor problems stops them growing into major issues that could limit walking or require surgery. nhs.uk
17. Massage and manual therapy
Gentle massage, myofascial release, and joint mobilization may reduce muscle tension and improve comfort. The purpose is short-term relief from stiffness and pain, and improved body awareness. The mechanism is increased blood flow, reduced sympathetic nervous system activity, and activation of “gate control” pathways in the spinal cord, which can dampen pain signals. Manual therapy is usually combined with exercises, not used alone. Physiopedia+1
18. Hydrotherapy / aquatic therapy
Exercising in warm water can be easier for people with weak legs or balance problems. The purpose is to allow safe practice of walking, stretching, and strengthening without the fear of falling. The mechanism is buoyancy: water supports body weight, reduces joint loading, and provides gentle resistance from all directions, which can help muscles work in a more comfortable way. The Physio Lab
19. Yoga, tai chi, and gentle mind–body exercises
Slow, controlled movements combined with breathing exercises can improve flexibility, posture, body awareness, and mental calm. The purpose is to improve balance and reduce stress, which can worsen pain. The mechanism is dual: movement helps joints and muscles, while focused breathing and attention reduce anxiety and muscle tension, which often amplifies pain signals. Charcot-Marie-Tooth Association+1
20. Support groups and peer counselling
CMT2V is rare, and people often feel isolated. Joining online or local support groups connects individuals with others facing similar challenges. The purpose is emotional support, sharing of practical tips, and encouragement to stay active in care. The mechanism is social connection: feeling understood and less alone can reduce depression and improve motivation to follow treatment plans. Global Genes+1
Drug Treatments
There are no drugs approved specifically to cure CMT or CMT2V. Medicines below are mainly used off-label to control neuropathic pain, muscle symptoms, mood, or sleep. Dose ranges are from FDA labels or clinical practice for other neuropathic conditions; they are examples only and must be individualized by a doctor. PMC+2Charcot-Marie-Tooth Association+2
1. Gabapentin
Gabapentin is an anticonvulsant often used for neuropathic pain. In adults with post-herpetic neuralgia, labels describe titration up to about 1800–3600 mg per day in divided doses, adjusted by response. FDA Access Data+1 It reduces abnormal firing of nerve cells by binding to calcium channels. Purpose is to lower burning, shooting pain. Side effects can include dizziness, sleepiness, weight gain, and swelling of legs.
2. Pregabalin (Lyrica, including Lyrica CR)
Pregabalin is another gabapentinoid, FDA-approved for several neuropathic pain conditions. FDA Access Data+2FDA Access Data+2 Typical adult doses for neuropathic pain are often in the range 150–600 mg per day in divided doses, as directed by a doctor. It binds to calcium channels to reduce release of excitatory neurotransmitters. Purpose is pain relief and improved sleep. Common side effects are dizziness, drowsiness, blurred vision, swelling, and weight gain.
3. Duloxetine
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) approved for diabetic neuropathic pain and fibromyalgia. PMC+2FDA Access Data+2 Adult neuropathic pain doses are usually around 60–120 mg daily. It increases serotonin and norepinephrine in pain pathways, which dampens pain signals. Side effects may include nausea, dry mouth, sleep changes, sweating, and sometimes increased blood pressure.
4. Venlafaxine
Venlafaxine is another SNRI sometimes used off-label for neuropathic pain. It is usually taken once or twice daily in extended-release or immediate-release form, at doses adjusted by the doctor. The purpose is to improve pain and also treat depression or anxiety, which often coexist in chronic nerve diseases. It works by boosting serotonin and norepinephrine. Side effects may include nausea, headache, insomnia, or raised blood pressure. Charcot-Marie-Tooth Association+1
5. Amitriptyline
Amitriptyline is a tricyclic antidepressant (TCA) used in low doses for nerve pain. It is often taken at night because it can cause drowsiness. The mechanism is blocking reuptake of serotonin and norepinephrine and blocking some pain-related receptors. Purpose is to reduce pain and improve sleep. Side effects can include dry mouth, constipation, blurred vision, weight gain, and sometimes heart rhythm changes at higher doses. Charcot-Marie-Tooth Association+1
6. Nortriptyline
Nortriptyline is a related TCA that is sometimes better tolerated than amitriptyline. It is used in similar low doses at bedtime for neuropathic pain. The purpose and mechanism are similar: strengthening descending pain-inhibiting pathways in the spinal cord. Side effects overlap with amitriptyline but may be slightly milder; they include dry mouth, dizziness, constipation, and possible heart effects, especially in older adults. Charcot-Marie-Tooth Association
7. Topical lidocaine patches
Lidocaine 5% patches are applied to painful areas of skin for limited hours each day. They work by numbing the local nerves in the skin, blocking sodium channels that carry pain signals. The purpose is targeted relief of focal burning or allodynia without strong whole-body side effects. Mild skin irritation or rash at the patch site can occur. These are particularly useful if pain is concentrated in one area, such as the top of the foot. Charcot-Marie-Tooth Association+1
8. Topical capsaicin cream or patches
Capsaicin, the substance that makes chili peppers hot, can desensitize pain fibers when applied repeatedly. High-concentration patches are sometimes used for localized neuropathic pain under specialist supervision. The purpose is to reduce ongoing burning pain. Mechanism is “defunctionalization” of TRPV1-expressing nerve endings. Side effects include burning and redness at the application site, especially with first uses. Charcot-Marie-Tooth Association+1
9. NSAIDs (e.g., ibuprofen, naproxen)
Non-steroidal anti-inflammatory drugs may help musculoskeletal pain from strained muscles and joints but are usually less effective for pure neuropathic pain. The purpose is to reduce inflammation and mild to moderate aches. They work by blocking cyclo-oxygenase enzymes and lowering prostaglandin production. Common side effects include stomach upset and, with long-term use, risk of ulcers, kidney effects, and raised blood pressure.
10. Acetaminophen (paracetamol)
Acetaminophen can be used for general aches or after activity. The mechanism is not fully understood but involves central pain-modulating pathways. The purpose is mild pain relief with usually fewer stomach side effects than NSAIDs when used correctly. Overdose, however, can damage the liver, so total daily dose limits set by guidelines must never be exceeded.
11. Baclofen
Baclofen is a muscle relaxant used for spasticity and sometimes for severe muscle cramps. In CMT2V, it may be considered if cramps or stiffness are troublesome. It acts on GABA-B receptors in the spinal cord to reduce reflex muscle overactivity. Side effects can include drowsiness, dizziness, and muscle weakness, so doses must be increased slowly and never stopped suddenly. Province of British Columbia
12. Tizanidine
Tizanidine is another muscle relaxant that acts on alpha-2 receptors in the central nervous system. It may help painful muscle spasms. Purpose is to increase comfort and range of motion. Side effects include sleepiness, dry mouth, and low blood pressure, so doctors usually start with low doses and monitor carefully. Province of British Columbia
13. Tramadol (with caution)
Tramadol is a weak opioid with additional serotonin and norepinephrine effects. Sometimes it is used for short-term rescue pain control when other options are not enough. It changes pain processing in the brain and spinal cord. Because it is an opioid, it carries risks of dependence, nausea, constipation, and sleepiness, so many guidelines recommend using it only briefly and under close medical supervision. Province of British Columbia
14. Carbamazepine
Carbamazepine is an anticonvulsant often used for trigeminal neuralgia and sometimes other neuropathic pains. It stabilizes sodium channels in overactive nerve cells. The purpose is to reduce sharp, electric shock-like pains. Side effects can include dizziness, drowsiness, low sodium, and rare but serious blood or skin reactions, so blood tests and monitoring are needed. Province of British Columbia
15. Oxcarbazepine
Oxcarbazepine is related to carbamazepine but may have a different side-effect profile. It is also sometimes used for neuropathic pain. The mechanism is sodium channel modulation in hyperexcitable neurons. Side effects include dizziness, fatigue, and low sodium levels. Doctors choose and adjust the dose based on response and side-effect tolerability. Charcot-Marie-Tooth Association+1
16. Lamotrigine
Lamotrigine is another anticonvulsant that can be used off-label for some neuropathic pain conditions when other therapies fail. It stabilizes sodium channels and reduces glutamate release. Purpose is to decrease frequency and intensity of pain episodes. Side effects can include rash (rarely severe), dizziness, and headache, so the dose is increased very slowly. Province of British Columbia
17. Clonazepam (short-term, with caution)
Clonazepam is a benzodiazepine that enhances GABA activity. Sometimes it is used short-term for severe nocturnal cramps or anxiety related to chronic pain. The purpose is to improve sleep and reduce episodes of intense cramps. Because it can cause dependence, drowsiness, and falls, long-term use is usually avoided.
18. Low-dose opioids (specialist-supervised)
In very severe, refractory pain, a pain specialist may consider low-dose opioids such as morphine or oxycodone for limited periods. They act on opioid receptors to strongly reduce pain perception. However, risks include dependence, constipation, hormonal effects, and overdose. Non-opioid strategies are preferred whenever possible, and strict monitoring is essential. Province of British Columbia
19. Sleep medicines (for short-term insomnia)
Severe pain and discomfort often disturb sleep. Short-acting sleep medicines may be used briefly to break a cycle of insomnia. The purpose is to restore restorative sleep, which in turn reduces pain sensitivity and fatigue. Doctors choose specific drugs carefully because many sedatives can increase fall risk in people with weak legs and numb feet.
20. Antidepressants for mood and pain modulation
Depression and anxiety are common in chronic neuropathic disease. SSRIs or SNRIs chosen mainly for mood can indirectly reduce pain because a less depressed brain handles pain signals better. The purpose is to improve overall wellbeing, not only pain scores. Mechanism is adjustment of serotonin and other transmitters, which affects both mood and pain pathways. PMC+1
Dietary Molecular Supplements
(Evidence for supplements in CMT2V is limited. These are general nerve-health or pain-related nutrients; always discuss them with a doctor to avoid interactions.)
Alpha-lipoic acid – An antioxidant used in some diabetic neuropathy studies; it may reduce oxidative stress in nerves and improve symptoms in some people. Typical oral doses in studies are around 600 mg/day, but the benefit in CMT2V specifically is unproven.
Acetyl-L-carnitine – Helps mitochondrial energy production. Some small studies suggest possible benefit in certain neuropathies, but evidence is weak. Doses often range from 500–1000 mg two or three times daily in research settings.
Omega-3 fatty acids (EPA/DHA) – Found in fish oil. They have anti-inflammatory and membrane-stabilizing effects that may slightly help nerve health and general cardiovascular health. Common supplement doses are 1–3 g of combined EPA/DHA per day.
Vitamin B1 (thiamine) and benfotiamine – Important for nerve metabolism. In deficiency states, B1 replacement helps neuropathy. In non-deficient CMT2V, benefit is uncertain, but standard multivitamin-level dosing is usually safe.
Vitamin B6 (pyridoxine, with caution) – Low B6 can cause neuropathy, but high doses can also damage nerves. If used, doses should stay within recommended dietary ranges unless closely supervised by a doctor.
Vitamin B12 (methylcobalamin) – B12 deficiency causes nerve damage. Correcting low B12 with oral or injectable forms can improve neuropathy due to deficiency, but it does not cure genetic CMT2V. Screening and replacement when low is important.
Vitamin D – Supports bone and muscle health. People with limited mobility often have low vitamin D, which can worsen weakness and fracture risk. Supplement doses depend on blood levels and local guidelines.
Magnesium – Sometimes used to help muscle cramps and overall muscle function. It supports many cellular enzymes. Too much can cause diarrhoea or, in kidney disease, serious problems, so proper dosing is needed.
Coenzyme Q10 – A mitochondrial cofactor with antioxidant properties. It is used in some mitochondrial and heart conditions. Evidence in CMT is limited, but some people report improved fatigue; common doses are 100–300 mg/day.
Curcumin (from turmeric) – Has anti-inflammatory and antioxidant effects. It may modestly help general joint and muscle discomfort, but it is not a proven treatment for CMT2V. Absorption-enhanced preparations may be more effective; dose ranges vary widely.
Regenerative and Stem-Cell-Related Drugs
Gene therapy targeting CMT-related genes – For some CMT types, researchers are exploring viral vectors to deliver healthy gene copies or silence harmful ones. For NAGLU-related disease like CMT2V, this is still in very early or theoretical stages. The idea is to correct the genetic cause at the DNA or RNA level.
Muscle-targeted small-molecule therapies (e.g., NMD670 in trials) – Some experimental drugs aim to make muscle fibers respond better to weak nerve signals, improving strength without fixing the nerve itself. These are taken by mouth and act directly on muscle receptors or channels. None are yet approved, but clinical trials are ongoing in broader CMT populations. NMD Pharma+1
Neurotrophic factor therapies – Laboratory work is studying growth factors that support nerve survival, such as NGF or NT-3-like molecules. The goal is to protect or regrow damaged axons. Delivery methods and side effects remain major challenges, so this is not available in routine practice. PMC
Cell-based regenerative therapies – Experimental studies use stem cells or progenitor cells to support damaged peripheral nerves, either by direct replacement or by releasing helpful growth factors. Most research is in animals or early human trials; long-term safety and true effectiveness for CMT2V are unknown.
CRISPR and gene-editing strategies – Gene-editing tools such as CRISPR are being researched to directly fix disease-causing variants. For CMT, this is still largely pre-clinical. The mechanism is editing DNA sequences to remove or correct the mutation. At present, it is not a clinical therapy but a future hope. PMC+1
Immune-modulating therapies (very limited role) – Unlike immune neuropathies, CMT2V is not caused by autoimmune attack, so classic “immunity booster” or immunosuppressive drugs (IVIG, steroids) are generally not helpful. The regenerative focus is on genetics and nerve support, not on immune modulation.
Surgeries
Foot deformity correction (osteotomy) – In people with high arches and twisted feet, surgeons may cut and realign foot bones. The purpose is to place the foot in a more plantigrade (flat and stable) position, reduce pain, and make walking in shoes or braces easier. Medscape eMedicine+1
Tendon transfer surgery
When some muscles are strong and others are weak, surgeons can detach a healthy tendon and reattach it to help a weak movement, such as lifting the foot. The purpose is to improve foot clearance and reduce trips and falls.Joint fusion (arthrodesis) of ankle or toes
If joints are severely unstable, painful, or deformed and cannot be corrected with softer methods, they may be fused in a better position. The purpose is a stable, pain-reduced foot that can fit in a shoe, even though joint motion is lost.Spinal surgery for severe scoliosis
Some people with neuromuscular disease develop spinal curvature that affects breathing or sitting balance. In rare severe cases, spinal fusion or corrective surgery may be advised. The purpose is to prevent progression and protect lung function and posture.Nerve decompression procedures (selected cases)
If a nerve is trapped in a tight tunnel, such as the carpal tunnel at the wrist, decompression surgery can relieve local symptoms. In hereditary neuropathy, benefit is variable, but in cases of clear entrapment, it can reduce numbness and weakness in that nerve’s territory. Medscape eMedicine+1
Prevention and Risk-Reduction Strategies
Because CMT2V is genetic, it cannot currently be prevented. However, complications can be reduced:
Keep to a regular physiotherapy and stretching program.
Use braces, good shoes, and assistive devices as recommended to prevent falls.
Avoid known neurotoxic drugs (for example, some chemotherapy agents) whenever safer alternatives exist; your doctors must always know you have CMT. PMC+1
Maintain healthy body weight to reduce stress on weak feet and joints.
Protect your feet from burns and injuries, as sensation may be reduced.
Do daily foot checks for blisters, cuts, or colour changes.
Stop smoking and limit heavy alcohol use, as both can worsen nerve damage.
Get recommended vaccinations (like flu, COVID-19, and pneumonia when appropriate) to reduce illness-related weakness.
Keep chronic conditions such as diabetes or thyroid problems well-controlled.
Seek early treatment for new pain, deformity, or walking changes instead of waiting for them to become severe.
When to See Doctors
You should see a doctor, ideally a neurologist experienced in neuromuscular diseases, for any new or worsening symptoms. Important times to seek care include: rapidly increasing pain, sudden change in walking, frequent falls, new hand weakness, or difficulty with swallowing or breathing. Regular follow-up visits allow monitoring of strength, sensation, joint alignment, and function over time. Mayo Clinic+1
A physiotherapist, occupational therapist, and podiatrist should be involved early, not only when disability is already severe. If mood problems, anxiety, or sleep disturbance appear, a psychologist or psychiatrist can help. Genetic counselling is important for people who want to discuss family planning, as CMT2V is autosomal dominant and each child has a significant chance of inheriting the variant. Monarch Initiative+1
What to Eat and What to Avoid
Eat a balanced diet with plenty of vegetables, fruits, whole grains, and lean protein to support general health and muscle repair.
Eat enough protein (from fish, eggs, beans, dairy, or lean meat) to help maintain muscle mass.
Eat foods rich in B-vitamins and healthy fats, such as leafy greens, legumes, nuts, seeds, and oily fish.
Eat calcium- and vitamin-D-rich foods (dairy, fortified plant milks) to help keep bones strong, especially if mobility is reduced.
Avoid heavy alcohol use because it can cause additional nerve damage and worsen balance.
Avoid extreme crash diets that cause rapid weight loss and possible vitamin deficits.
Avoid very salty, sugary, ultra-processed foods in large amounts, as they increase weight and cardiovascular risk.
Avoid energy drinks and very high caffeine intake, which may worsen sleep and anxiety linked to chronic pain.
Avoid unregulated “miracle” supplements advertised as cures for neuropathy; evidence is usually weak or absent.
Work with a dietitian if you have other conditions like diabetes, kidney disease, or food allergies, so your diet supports both CMT2V and your general health.
Frequently Asked Questions
1. Is autosomal dominant axonal Charcot-Marie-Tooth disease type 2V curable?
At present CMT2V is not curable. Treatment focuses on reducing pain, protecting muscles and joints, and keeping people active and independent for as long as possible. Research into gene therapy and new drugs is active but still experimental. PMC+2PMC+2
2. Will CMT2V shorten my life?
Most forms of CMT, including CMT2, progress slowly and usually do not shorten life expectancy. Quality of life can be affected by pain, weakness, and mobility problems, but good multidisciplinary care can help many people remain active for decades. Mayo Clinic+1
3. What is special about type 2V compared with other CMT types?
Type 2V is an axonal, autosomal dominant subtype associated with mutations in the NAGLU gene and often presents as adult-onset painful axonal polyneuropathy. Symptoms can be similar to other CMT2 forms, but the genetic cause and exact pattern of pain and weakness may differ. Mendelian+3Genetic Diseases Center+3Orpha.net+3
4. How is CMT2V diagnosed?
Doctors take a detailed history and do a neurological exam, nerve conduction studies, and sometimes electromyography. Genetic testing confirms the diagnosis and identifies the specific gene variant. Other causes of neuropathy, such as diabetes, vitamin deficiency, or autoimmune disease, are usually ruled out. Mayo Clinic+1
5. Can exercise make CMT2V worse?
Excessive, high-impact exercise that causes repeated injuries is not helpful, but well-planned, low-impact exercise guided by a physiotherapist usually helps. It can maintain strength, balance, and joint range without over-straining weak nerves and muscles. Physiopedia+2ScienceDirect+2
6. Are there FDA-approved drugs specifically for CMT2V?
No. FDA approvals for neuropathic pain mainly cover conditions such as diabetic neuropathy and post-herpetic neuralgia. Drugs like pregabalin and duloxetine are sometimes used to treat pain in CMT, but this is off-label and aimed at symptoms, not the root genetic cause. FDA Access Data+4PMC+4FDA Access Data+4
7. Will I need a wheelchair?
Many people with CMT walk all their lives, sometimes with braces or a cane. Others may use a wheelchair for long distances or later in life. Early use of orthotics, physiotherapy, and good foot care can delay or reduce the need for wheelchairs. Medscape eMedicine+1
8. Can surgery cure my CMT2V?
Surgery cannot repair damaged nerves or fix the genetic cause. It is used to correct deformities, improve alignment, and reduce pain, so walking becomes easier. Think of surgery as a supportive tool rather than a cure. Medscape eMedicine+1
9. Is pregnancy safe if I have CMT2V?
Many people with CMT have successful pregnancies. However, pregnancy can temporarily worsen weakness or balance in some cases. Genetic counselling is important because each child of a person with autosomal dominant CMT2V has a significant chance of inheriting the condition. Obstetric and neurology teams can plan safe care. Monarch Initiative+1
10. What medicines should I avoid?
Certain drugs, especially some chemotherapy agents and a few antibiotics, can damage peripheral nerves. If you have CMT2V, always tell every doctor and dentist about your neuropathy so they can check drug lists and avoid high-risk medicines whenever possible. PMC+1
11. Can children develop CMT2V symptoms?
Although CMT2V is often described as adult-onset, the age of onset can vary. Some people may notice mild clumsiness, frequent ankle sprains, or high arches earlier. Any child with signs of neuropathy and a family history should be assessed by a paediatric neurologist. Orpha.net+2Monarch Initiative+2
12. Does CMT2V affect organs other than nerves?
CMT2V mainly affects peripheral nerves. It typically does not directly damage the brain, heart, liver, or kidneys. However, reduced mobility can indirectly affect bones, joints, weight, and cardiovascular health, so whole-body care is still important. PMC+1
13. Are there clinical trials I can join?
Yes, there are clinical trials for various CMT types, especially targeting muscle function or specific genetic forms, though they may not always include CMT2V. Patient organizations and clinical trial registries can help identify suitable studies. Participation helps advance knowledge and may offer early access to potential new treatments. PMC+2NMD Pharma+2
14. How can my family get support?
Specialist neuromuscular centres, rare-disease organizations, and CMT foundations offer education, counselling, peer support, and sometimes small grants for equipment. They can also help navigate school and work accommodations. Global Genes+1
15. What is the most important thing I can do today?
The most important step is to build a long-term care plan with a neurologist and rehabilitation team. Regular exercise, good foot care, pain management, and realistic pacing of activities help protect your independence. Learning about CMT2V and connecting with others can make the journey feel less lonely and more manageable. Muscular Dystrophy Association+3Physiopedia+3ScienceDirect+3
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
